中国生物科技服务：完成发行本金总额3500万美元的可换股债券

Group 1 - The core point of the article is that China Biotechnology Services has completed the issuance of convertible bonds totaling $35 million, with all conditions of the subscription agreement met [1] - The convertible bonds were issued on February 20, 2026, according to the terms and conditions of the subscription agreement [1] - Prior to the issuance of the new convertible bonds, there remains an outstanding principal amount of $6 million from the 2024 convertible bonds, which can be converted into a total of 39.25 million shares at a conversion price of HKD 1.20 per share [1]